Quoin Pharmaceuticals Ltd
Research Quoin Pharmaceuticals Ltd (QNRX) on Bullrun: market cap USD 10.18M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerQNRX
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 10.18M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 16.99M
- Free cash flow-USD 4.87M
Valuation Snapshot
latest market cap is USD 10.18M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 15.80M | -USD 13.54M | n/a | -21.23 | USD 3.82M | n/a | USD 13.12M |
| FY2024 | USD 0 | -USD 8.96M | -USD 7.86M | n/a | -546.07 | USD 3.62M | n/a | USD 9.20M |
| FY2023 | n/a | -USD 8.69M | n/a | n/a | n/a | USD 2.40M | n/a | USD 5.66M |
| FY2022 | n/a | -USD 9.38M | n/a | n/a | n/a | USD 2.86M | n/a | USD 7.41M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 10.18M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 21.62M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 5.82M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 4.84M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 6.86M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 15.29M | n/a | n/a | n/a |
About Quoin Pharmaceuticals Ltd
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Quoin Pharmaceuticals Ltd's market cap?
Quoin Pharmaceuticals Ltd's market capitalization is USD 10.18M.
What does Quoin Pharmaceuticals Ltd do?
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis.